Intracellular acidification is discussed to play a pivotal role in the process of programmed cell death by providing an intracellular environment optimal for the activation of caspases and the execution of apoptosis. Using three human colon epithelial cell lines we tested whether effects on early and late apoptosis markers can be related to changes in intracellular pH (pHi). Caspase-3-like activity and plasma membrane disintegration served as measures of early apoptosis whereas nuclear fragmentation served as indicator of late apoptosis events. The pHi was measured using the pH-sensitive dye 2´, 7´-bis (2-carboxyethyl-5-(6)-carboxyfluorescein. Six flavonoids differing in apoptosis inducing activity were employed as tools. In HT-29 cells, quercetin and flavone proved to potently increase apoptosis without altering pHi. In Caco-2 cells, quercetin and flavone increased early and late apoptosis parameters associated with a concomitant decline in pHi. However, addition of imidazole prevented the acidification without altering the apoptotic response to the flavonoids. In NCOL-1 cells, only quercetin was able to induce apoptosis and changes observed correlate with the observed initial intracellular acidification rate. Here too, imidazole prevented the pHi decline but failed to affect apoptosis execution. In conclusion, apoptosis in human colonocytes is not affected by alterations in pHi.

This content is only available via PDF.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.